ATNM Competitors & Alternatives
Compare Actinium Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ATNM
Main Stock$1.03
Tradestie Score
35
Market Cap
$49.91M
P/E Ratio
3.0
Revenue Growth
-1.0%
Analyst Upside
+239.8%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$35.55
|
$110.20M | - | 42 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 56 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.00
|
$84.52M | - | 50 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.19
|
$71.32M | - | 51 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.91
|
$67.94M | - | 38 | Compare |
|
MBRX
Moleculin Biotech, Inc.
|
$0.71
|
$26.23M | 0.0 | 36 | Compare |
|
CTXR
Citius Pharmaceuticals Inc. Common
|
$0.59
|
$23.31M | - | 63 | Compare |
|
CLRB
Cellectar Biosciences INC NEW
|
$2.37
|
$18.42M | - | 43 | Compare |
|
BLRX
BioLineRX Ltd
|
$2.67
|
$16.50M | - | 47 | Compare |
|
GNPX
Genprex, Inc. Common Stock
|
$3.50
|
$7.59M | 0.1 | 51 | Compare |
More ATNM Analysis
Data updated: Sep 07, 2026 | Industry: Biotechnology (SIC 2834)
242 stocks in this industry